The case for evaluation of double mutant heat-labile toxin as an adjuvant to improve oral cholera vaccine immunogenicity. [PDF]
Bourgeois AL +5 more
europepmc +1 more source
Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial. [PDF]
Hamonic G +13 more
europepmc +1 more source
Engineered PCV2 VLPs for Antigen Delivery: A Platform for Next-Generation Veterinary Vaccines. [PDF]
Ding P, Liu Y, Wang C, Wang A.
europepmc +1 more source
Combination of adenovirus vector and subunit protein elicits a robust immune response against the SARS-CoV-2 Omicron variant. [PDF]
Ye C +15 more
europepmc +1 more source
Flipping the script: Using mucosal immune obstacles to inform vaccine design. [PDF]
Antia A, Ding S.
europepmc +1 more source
A Comparative Review of Veterinary and Human Vaccine Development Strategies: Insights into Herpesvirus Vaccinology from Latency to Elimination. [PDF]
Liu G, Zhao X, Lin Y, Wang X, Liu D.
europepmc +1 more source
Immune-Based Prevention and Therapy Against Coccidioidomycosis: Current and Emerging Approaches. [PDF]
Abdul-Baki N, Navarro R, Yu JJ, Hung CY.
europepmc +1 more source
Nano-adjuvants enhance the immunogenicity and safety of infectious bursal disease virus vaccines: a comprehensive review. [PDF]
Asif TA +5 more
europepmc +1 more source
Vaccination in systemic lupus erythematosus. [PDF]
Mok TC, Mok CC.
europepmc +1 more source
Co-administration of oral killed whole-cell recombinant cholera toxin B-subunit vaccine (WC-rCTB) and live Salmonella Typhi Ty21a vaccine: a prospective randomized open-label trial. [PDF]
Riekkinen M +6 more
europepmc +1 more source

